Eurofins Scientific SE Cash Flow Conversion Efficiency

Latest as of December 2022: 0.069x

Eurofins Scientific SE cash flow conversion efficiency. Based on the latest financial reports, Eurofins Scientific SE (ESF0) has a cash flow conversion efficiency ratio of 0.069x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€334.05 Million ≈ $390.54 Million USD) by net assets (€4.85 Billion ≈ $5.67 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ESF0 market cap overview for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Eurofins Scientific SE (2016–2025)

Cash flow conversion efficiency of Eurofins Scientific SE from 2016 to 2025. This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ESF0 stock price for real-time trading data and today's change.

Eurofins Scientific SE Cash Flow Conversion Ratio Explained

Eurofins Scientific SE cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency. Review ESF0 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Dayforce Inc.
NYSE:DAY
0.012x
Aier Eye Hospital Group
SHE:300015
0.069x
LG Chemicals
KO:051910
0.053x
BUDWEISER BREW.UNSP.ADR/4
F:4BB1
N/A
Guangdong Haid Group Co Ltd
SHE:002311
0.080x
Applied Industrial Technologies
NYSE:AIT
0.054x
JAMES HARDIE INDUST.ADR/1
F:JHA0
N/A
Korea Shipbuilding & Offshore Engineering Co Ltd
KO:009540
0.138x

Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2016–2025)

The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2016 to 2025. Also see ESF0 current and non-current assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.58 Billion
≈ $5.35 Billion
€1.40 Billion
≈ $1.64 Billion
0.306x +24.79%
2024-12-31 €5.38 Billion
≈ $6.30 Billion
€1.32 Billion
≈ $1.54 Billion
0.245x +23.62%
2023-12-31 €5.14 Billion
≈ $6.01 Billion
€1.02 Billion
≈ $1.19 Billion
0.198x -15.41%
2022-12-31 €4.85 Billion
≈ $5.67 Billion
€1.14 Billion
≈ $1.33 Billion
0.234x -27.51%
2021-12-31 €4.68 Billion
≈ $5.47 Billion
€1.51 Billion
≈ $1.77 Billion
0.323x -1.84%
2020-12-31 €3.72 Billion
≈ $4.34 Billion
€1.22 Billion
≈ $1.43 Billion
0.329x +40.74%
2019-12-31 €2.90 Billion
≈ $3.39 Billion
€677.90 Million
≈ $792.54 Million
0.234x +17.07%
2018-12-31 €2.72 Billion
≈ $3.18 Billion
€543.90 Million
≈ $635.88 Million
0.200x +22.41%
2017-12-31 €2.48 Billion
≈ $2.90 Billion
€405.12 Million
≈ $473.63 Million
0.163x -22.89%
2016-12-31 €1.76 Billion
≈ $2.05 Billion
€371.84 Million
≈ $434.72 Million
0.212x --

About Eurofins Scientific SE

F:ESF0 Germany Diagnostics & Research
Market Cap
$12.10 Billion
€10.35 Billion EUR
Market Cap Rank
#1997 Global
#431 in Germany
Share Price
€59.14
Change (1 day)
+0.03%
52-Week Range
€55.08 - €72.98
All Time High
€123.83
About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more